Variant report
Variant | esv3391932 |
---|---|
Chromosome Location | chr8:20338072-20342370 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556445309 | chr8:20338091-20338092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150396759 | chr8:20338126-20338127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138157246 | chr8:20338137-20338138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148892507 | chr8:20338165-20338166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143605448 | chr8:20338168-20338169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564959726 | chr8:20338200-20338201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539984249 | chr8:20338234-20338235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188781593 | chr8:20338266-20338267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181545525 | chr8:20338285-20338286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550769977 | chr8:20338431-20338432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568932696 | chr8:20338460-20338461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12675270 | chr8:20338477-20338478 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs533592135 | chr8:20338486-20338487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548464853 | chr8:20338532-20338533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544392013 | chr8:20338536-20338537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58642906 | chr8:20338547-20338548 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs368142743 | chr8:20338580-20338581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185952094 | chr8:20338590-20338591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570938311 | chr8:20338595-20338596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190716958 | chr8:20338598-20338599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs28436903 | chr8:20340407-20340408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs147602464 | chr8:20340411-20340412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576279119 | chr8:20340413-20340414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543656794 | chr8:20340421-20340422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558059883 | chr8:20340457-20340458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138666914 | chr8:20340467-20340468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13275284 | chr8:20340510-20340511 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs566312131 | chr8:20340533-20340534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17092580 | chr8:20340536-20340537 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs541175313 | chr8:20340561-20340562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192233441 | chr8:20340575-20340576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183919121 | chr8:20340585-20340586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188337366 | chr8:20340613-20340614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12679719 | chr8:20340625-20340626 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs113667612 | chr8:20340647-20340648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527653160 | chr8:20340650-20340651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549686710 | chr8:20340651-20340652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142876271 | chr8:20340653-20340654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370171955 | chr8:20340663-20340664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191674022 | chr8:20340670-20340671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552605030 | chr8:20340740-20340741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572734591 | chr8:20340759-20340760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547549196 | chr8:20340778-20340779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79933032 | chr8:20340788-20340789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539490343 | chr8:20340842-20340843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557672291 | chr8:20340859-20340860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576147730 | chr8:20340861-20340862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374515641 | chr8:20340871-20340872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536987666 | chr8:20340886-20340887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555239367 | chr8:20340891-20340892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20337600-20338600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr8:20338000-20338200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:20338000-20338400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr8:20340400-20341800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:20340600-20341200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:20340600-20341400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr8:20340600-20342000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:20341000-20341400 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
9 | chr8:20341000-20342000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:20341400-20341800 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr8:20341600-20341800 | Enhancers | HUES64 Cell Line | embryonic stem cell |